A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies-Reference-Cited by-同舟云学术

A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies

Published:2024-08-07 Issue:16 Volume:13 Page:4632
ISSN:2077-0383
Container-title:Journal of Clinical Medicine
language:en
Short-container-title:JCM

Author:

Moghrabi Serin¹^ORCID,Abdlkadir Ahmed Saad¹^ORCID,Al-Hajaj Nabeela¹,Gnanasegaran Gopinath²,Kumar Rakesh³^ORCID,Syed Ghulam⁴,Bozkurt Murat Fani⁵^ORCID,Shukri Saad⁶,Obeidat Shahed¹,Khalaf Aysar⁷,Shahait Mohammed⁸^ORCID,Al-Nabhani Khalsa⁹,Al-Ibraheem Akram¹¹⁰^ORCID

Affiliation:

1. Department of Nuclear Medicine and PET/CT, King Hussein Cancer Center (KHCC), Amman 11941, Jordan

2. Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London NW3 2QG, UK

3. Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi 110608, India

4. Department of Nuclear Medicine, National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha 3050, Qatar

5. Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University, 06230 Ankara, Turkey

6. Al-Razi Outpatient Clinic of Internal Medicine, Baghdad 10044, Iraq

7. Department of Nuclear Medicine, Warith International Cancer Institute, Karbala 56001, Iraq

8. Surgery Department, Clemenceau Medical Center, Dubai 6869, United Arab Emirates

9. Radiology Department, Royal Hospital, Muscat 1331, Oman

10. School of Medicine, University of Jordan, Amman 11942, Jordan

Abstract

Non-tumorous kidney diseases include a variety of conditions affecting both the structure and function of the kidneys, thereby causing a range of health-related problems. Positron emission tomography/computed tomography (PET/CT) has emerged as a potential diagnostic tool, offering a multifaceted approach to evaluating non-tumorous kidney diseases. Its clinical significance extends beyond its conventional role in cancer imaging, enabling a comprehensive assessment of renal structure and function. This review explores the diverse applications of PET/CT imaging in the evaluation of non-cancerous kidney diseases. It examines PET/CT’s role in assessing acute kidney injuries, including acute pyelonephritis and other forms of nephritis, as well as chronic conditions such as immune complex-mediated glomerulonephritis and chronic kidney disease. Additionally, the review delves into PET/CT’s utility in evaluating complications in renal transplant recipients, identifying renal histiocytosis and detecting renal amyloidosis. The current review aims to promote further research and technological advancements to popularize PET/CT’s clinical utility in diagnosing and treating non-tumorous kidney diseases.

Publisher

MDPI AG

Link

https://www.mdpi.com/2077-0383/13/16/4632/pdf

Reference86 articles.

1. Epidemiology of chronic kidney disease: An update 2022;Kovesdy;Kidney Int. Suppl.,2022

2. Li, P.K.-T., Garcia-Garcia, G., Lui, S.-F., Andreoli, S., Fung, W.W.-S., Hradsky, A., Kumaraswami, L., Liakopoulos, V., Rakhimova, Z., and Saadi, G. (2020). Kidney health for everyone everywhere—From prevention to detection and equitable access to care. Braz. J. Med. Biol. Res., 53.

3. Positron emission tomography for benign and malignant disease;Visioni;Surg. Clin.,2011

4. Theranostics in Developing Countries: Addressing Challenges and Potentials from Training to Practice;World J. Nucl. Med.,2023

5. The utilization of positron emission tomography in the evaluation of renal health and disease;Amoabeng;Clin. Transl. Imaging,2022